131 related articles for article (PubMed ID: 33867228)
1. Adiponectin involved in portal flow hepatic extraction of 13C-methacetin in obesity and non-alcoholic fatty liver.
Di Ciaula A; Carbone F; Shanmugham H; Molina-Molina E; Bonfrate L; Ministrini S; Montecucco F; Portincasa P
Eur J Intern Med; 2021 Jul; 89():56-64. PubMed ID: 33867228
[TBL] [Abstract][Full Text] [Related]
2. (
Molina-Molina E; Shanmugam H; Di Ciaula A; Grattagliano I; Di Palo DM; Palmieri VO; Portincasa P
JHEP Rep; 2021 Feb; 3(1):100203. PubMed ID: 33490935
[TBL] [Abstract][Full Text] [Related]
3. Liver fat accumulation more than fibrosis causes early liver dynamic dysfunction in patients with non-alcoholic fatty liver disease.
Di Ciaula A; Shanmugam H; Ribeiro R; Pina A; Andrade R; Bonfrate L; Raposo JF; Macedo MP; Portincasa P
Eur J Intern Med; 2023 Jan; 107():52-59. PubMed ID: 36344354
[TBL] [Abstract][Full Text] [Related]
4. 13C-METHACETIN BREATHE TEST IN EARLY DIAGNOSTICS OF NON-ALCOHOLIC FATTY LIVER DISEASE.
Sklyarova HE
Wiad Lek; 2021; 74(3 cz 1):487-491. PubMed ID: 33813455
[TBL] [Abstract][Full Text] [Related]
5. Leptin/adiponectin ratio correlates with hepatic steatosis but not arterial stiffness in nonalcoholic fatty liver disease in Japanese population.
Mikami K; Endo T; Sawada N; Igarashi G; Kimura M; Hasegawa T; Iino C; Tomita H; Sawada K; Nakaji S; Matsuzaka M; Torok NJ; Fukuda S
Cytokine; 2020 Feb; 126():154927. PubMed ID: 31756645
[TBL] [Abstract][Full Text] [Related]
6. Utility of a 13C-methacetin breath test in evaluating hepatic injury in rats.
Shirin H; Aeed H; Shalev T; Sorin V; Stavinski S; Shahmurov M; Ilan Y; Avni Y
J Gastroenterol Hepatol; 2008 Nov; 23(11):1762-8. PubMed ID: 19120861
[TBL] [Abstract][Full Text] [Related]
7. [13C-methacetin breath test in chronic hepatitis C liver disease].
Oliveira AC; Reber M; Lanzoni V; Ferraz ML; Parise ER
Arq Gastroenterol; 2006; 43(1):41-4. PubMed ID: 16699617
[TBL] [Abstract][Full Text] [Related]
8. Liver breath tests non-invasively predict higher stages of non-alcoholic steatohepatitis.
Portincasa P; Grattagliano I; Lauterburg BH; Palmieri VO; Palasciano G; Stellaard F
Clin Sci (Lond); 2006 Aug; 111(2):135-43. PubMed ID: 16603025
[TBL] [Abstract][Full Text] [Related]
9. Serum adipokine levels in overweight patients and their relationship with non-alcoholic fatty liver disease.
Abenavoli L; Luigiano C; Guzzi PH; Milic N; Morace C; Stelitano L; Consolo P; Miraglia S; Fagoonee S; Virgilio C; Luzza F; De Lorenzo A; Pellicano R
Panminerva Med; 2014 Jun; 56(2):189-93. PubMed ID: 24994581
[TBL] [Abstract][Full Text] [Related]
10. 13C-Methacetin Breath Testing in Patients with Non-Alcoholic Fatty Liver Disease.
Kempiński R; Neubauer K; Wieczorek S; Dudkowiak R; Jasińska M; Poniewierka E
Adv Clin Exp Med; 2016; 25(1):77-81. PubMed ID: 26935501
[TBL] [Abstract][Full Text] [Related]
11. Role of 13C methacetin breath test for non invasive staging of liver fibrosis in patients with chronic hepatitis C.
Fierbinteanu-Braticevici C; Papacocea R; Tribus L; Cristian B
Indian J Med Res; 2014 Jul; 140(1):123-9. PubMed ID: 25222787
[TBL] [Abstract][Full Text] [Related]
12. Effects of MBOAT7 polymorphism and steatosis on liver function assessed by methacetin breath test.
Di Ciaula A; Bonfrate L; Shanmugam H; Weber SN; Krawczyk M; Portincasa P
Eur J Clin Invest; 2023 Aug; 53(8):e14003. PubMed ID: 37029745
[TBL] [Abstract][Full Text] [Related]
13. Serum concentration of adiponectin, leptin and resistin in obese children with non-alcoholic fatty liver disease.
Lebensztejn DM; Wojtkowska M; Skiba E; Werpachowska I; Tobolczyk J; Kaczmarski M
Adv Med Sci; 2009; 54(2):177-82. PubMed ID: 20022856
[TBL] [Abstract][Full Text] [Related]
14. The role of ¹³C-methacetin breath test for the non-invasive evaluation of nonalcoholic fatty liver disease.
Fierbinteanu-Braticevici C; Plesca DA; Tribus L; Panaitescu E; Braticevici B
J Gastrointestin Liver Dis; 2013 Jun; 22(2):149-56. PubMed ID: 23799213
[TBL] [Abstract][Full Text] [Related]
15. Adiponectin, a key adipokine in obesity related liver diseases.
Buechler C; Wanninger J; Neumeier M
World J Gastroenterol; 2011 Jun; 17(23):2801-11. PubMed ID: 21734787
[TBL] [Abstract][Full Text] [Related]
16. Hypoadiponectinaemia in nonalcoholic fatty liver disease obese women is associated with infrequent intake of dietary sucrose and fatty foods.
Magalhães GC; Feitoza FM; Moreira SB; Carmo AV; Souto FJ; Reis SR; Martins MS; Gomes da Silva MH
J Hum Nutr Diet; 2014 Apr; 27 Suppl 2():301-12. PubMed ID: 23790128
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast Growth Factor-21 to Adiponectin Ratio: A Potential Biomarker to Monitor Liver Fat in Children With Obesity.
Tas E; Bai S; Ou X; Mercer K; Lin H; Mansfield K; Buchmann R; Diaz EC; Oden J; Børsheim E; Adams SH; Dranoff J
Front Endocrinol (Lausanne); 2020; 11():654. PubMed ID: 33071964
[No Abstract] [Full Text] [Related]
18. Predicting Nonalcoholic Fatty Liver Disease through a Panel of Plasma Biomarkers and MicroRNAs in Female West Virginia Population.
Pillai SS; Lakhani HV; Zehra M; Wang J; Dilip A; Puri N; O'Hanlon K; Sodhi K
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32933141
[TBL] [Abstract][Full Text] [Related]
19. Serum adiponectin, leptin, resistin and RBP4 levels in obese and metabolic syndrome children with nonalcoholic fatty liver disease.
Boyraz M; Cekmez F; Karaoglu A; Cinaz P; Durak M; Bideci A
Biomark Med; 2013 Oct; 7(5):737-45. PubMed ID: 24044566
[TBL] [Abstract][Full Text] [Related]
20. Irisin in patients with nonalcoholic fatty liver disease.
Polyzos SA; Kountouras J; Anastasilakis AD; Geladari EV; Mantzoros CS
Metabolism; 2014 Feb; 63(2):207-17. PubMed ID: 24140091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]